EGFR and non-small cell lung carcinoma: Increased TMB classically correlates to decreased response to chemotherapy and an increased response to ICI therapy in NSCLC (110, 111), and in EGFRm NSCLC patients increased TMB correlates negatively with response to EGFR TKIs (112).